Cargando…

Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions

BACKGROUND: Tracking the dissemination of specific Mycobacterium tuberculosis (Mtb) strains using genotyped Mtb isolates from tuberculosis patients is a routine public health practice in the United States. The present study proposes a standardized cluster investigation method to identify epidemiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Teeter, Larry D., Vempaty, Padmaja, Nguyen, Duc T. M., Tapia, Jane, Sharnprapai, Sharon, Ghosh, Smita, Kammerer, J. Steven, Miramontes, Roque, Cronin, Wendy A., Graviss, Edward A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075185/
https://www.ncbi.nlm.nih.gov/pubmed/27769182
http://dx.doi.org/10.1186/s12879-016-1937-9
_version_ 1782461816236933120
author Teeter, Larry D.
Vempaty, Padmaja
Nguyen, Duc T. M.
Tapia, Jane
Sharnprapai, Sharon
Ghosh, Smita
Kammerer, J. Steven
Miramontes, Roque
Cronin, Wendy A.
Graviss, Edward A.
author_facet Teeter, Larry D.
Vempaty, Padmaja
Nguyen, Duc T. M.
Tapia, Jane
Sharnprapai, Sharon
Ghosh, Smita
Kammerer, J. Steven
Miramontes, Roque
Cronin, Wendy A.
Graviss, Edward A.
author_sort Teeter, Larry D.
collection PubMed
description BACKGROUND: Tracking the dissemination of specific Mycobacterium tuberculosis (Mtb) strains using genotyped Mtb isolates from tuberculosis patients is a routine public health practice in the United States. The present study proposes a standardized cluster investigation method to identify epidemiologic-linked patients in Mtb genotype clusters. The study also attempts to determine the proportion of epidemiologic-linked patients the proposed method would identify beyond the outcome of the conventional contact investigation. METHODS: The study population included Mtb culture positive patients from Georgia, Maryland, Massachusetts and Houston, Texas. Mtb isolates were genotyped by CDC’s National TB Genotyping Service (NTGS) from January 2006 to October 2010. Mtb cluster investigations (CLIs) were conducted for patients whose isolates matched exactly by spoligotyping and 12-locus MIRU-VNTR. CLIs were carried out in four sequential steps: (1) Public Health Worker (PHW) Interview, (2) Contact Investigation (CI) Evaluation, (3) Public Health Records Review, and (4) CLI TB Patient Interviews. Comparison between patients whose links were identified through the study’s CLI interviews (Step 4) and patients whose links were identified earlier in CLI (Steps 1–3) was conducted using logistic regression. RESULTS: Forty-four clusters were randomly selected from the four study sites (401 patients in total). Epidemiologic links were identified for 189/401 (47 %) study patients in a total of 201 linked patient-pairs. The numbers of linked patients identified in each CLI steps were: Step 1 - 105/401 (26.2 %), Step 2 - 15/388 (3.9 %), Step 3 - 41/281 (14.6 %), and Step 4 - 28/119 (30 %). Among the 189 linked patients, 28 (14.8 %) were not identified in previous CI. No epidemiologic links were identified in 13/44 (30 %) clusters. CONCLUSIONS: We validated a standardized and practical method to systematically identify epidemiologic links among patients in Mtb genotype clusters, which can be integrated into the TB control and prevention programs in public health settings. The CLI interview identified additional epidemiologic links that were not identified in previous CI. One-third of the clusters showed no epidemiologic links despite being extensively investigated, suggesting that some improvement in the interviewing methods is still needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1937-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5075185
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50751852016-10-27 Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions Teeter, Larry D. Vempaty, Padmaja Nguyen, Duc T. M. Tapia, Jane Sharnprapai, Sharon Ghosh, Smita Kammerer, J. Steven Miramontes, Roque Cronin, Wendy A. Graviss, Edward A. BMC Infect Dis Research Article BACKGROUND: Tracking the dissemination of specific Mycobacterium tuberculosis (Mtb) strains using genotyped Mtb isolates from tuberculosis patients is a routine public health practice in the United States. The present study proposes a standardized cluster investigation method to identify epidemiologic-linked patients in Mtb genotype clusters. The study also attempts to determine the proportion of epidemiologic-linked patients the proposed method would identify beyond the outcome of the conventional contact investigation. METHODS: The study population included Mtb culture positive patients from Georgia, Maryland, Massachusetts and Houston, Texas. Mtb isolates were genotyped by CDC’s National TB Genotyping Service (NTGS) from January 2006 to October 2010. Mtb cluster investigations (CLIs) were conducted for patients whose isolates matched exactly by spoligotyping and 12-locus MIRU-VNTR. CLIs were carried out in four sequential steps: (1) Public Health Worker (PHW) Interview, (2) Contact Investigation (CI) Evaluation, (3) Public Health Records Review, and (4) CLI TB Patient Interviews. Comparison between patients whose links were identified through the study’s CLI interviews (Step 4) and patients whose links were identified earlier in CLI (Steps 1–3) was conducted using logistic regression. RESULTS: Forty-four clusters were randomly selected from the four study sites (401 patients in total). Epidemiologic links were identified for 189/401 (47 %) study patients in a total of 201 linked patient-pairs. The numbers of linked patients identified in each CLI steps were: Step 1 - 105/401 (26.2 %), Step 2 - 15/388 (3.9 %), Step 3 - 41/281 (14.6 %), and Step 4 - 28/119 (30 %). Among the 189 linked patients, 28 (14.8 %) were not identified in previous CI. No epidemiologic links were identified in 13/44 (30 %) clusters. CONCLUSIONS: We validated a standardized and practical method to systematically identify epidemiologic links among patients in Mtb genotype clusters, which can be integrated into the TB control and prevention programs in public health settings. The CLI interview identified additional epidemiologic links that were not identified in previous CI. One-third of the clusters showed no epidemiologic links despite being extensively investigated, suggesting that some improvement in the interviewing methods is still needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1937-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-21 /pmc/articles/PMC5075185/ /pubmed/27769182 http://dx.doi.org/10.1186/s12879-016-1937-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Teeter, Larry D.
Vempaty, Padmaja
Nguyen, Duc T. M.
Tapia, Jane
Sharnprapai, Sharon
Ghosh, Smita
Kammerer, J. Steven
Miramontes, Roque
Cronin, Wendy A.
Graviss, Edward A.
Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions
title Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions
title_full Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions
title_fullStr Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions
title_full_unstemmed Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions
title_short Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions
title_sort validation of genotype cluster investigations for mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous united states jurisdictions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075185/
https://www.ncbi.nlm.nih.gov/pubmed/27769182
http://dx.doi.org/10.1186/s12879-016-1937-9
work_keys_str_mv AT teeterlarryd validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT vempatypadmaja validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT nguyenductm validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT tapiajane validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT sharnprapaisharon validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT ghoshsmita validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT kammererjsteven validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT miramontesroque validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT croninwendya validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT gravissedwarda validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions
AT validationofgenotypeclusterinvestigationsformycobacteriumtuberculosisapplicationresultsfor44clustersfromfourheterogeneousunitedstatesjurisdictions